←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Antisense Oligonucleotides
Eric Swayze
PhD
🏢Ionis Pharmaceuticals🌐USA
Executive Vice President of Research
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Eric Swayze has led ASO chemistry at Ionis Pharmaceuticals including the development of cEt (constrained ethyl) chemistry that increased potency and enabled approved drugs. His work underpins the Ionis oncology ASO pipeline. He is a senior figure in ASO drug design.
Share:
🧪Research Fields 研究领域
ASO chemistry
cEt chemistry
generation 2.5 ASO
cancer ASO pipeline
oligonucleotide modifications
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Eric Swayze 的研究动态
Follow Eric Swayze's research updates
留下邮箱，当我们发布与 Eric Swayze（Ionis Pharmaceuticals）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment